Selkirk Pharma Appoints Colleen Dixon as New CEO

Share This Post

Key Highlights

  • Selkirk Pharma announces Colleen Dixon as new CEO.
  • Dixon brings over 30 years of biopharma experience.
  • Formerly VP of Program Management at Selkirk Pharma.
  • Focus on strategic growth, operational excellence, and industry partnerships.

Source: Business Wire

Notable Quotes

  • “It is my distinct pleasure to welcome Colleen Dixon as the new Chief Executive Officer of Selkirk Pharma. With Colleen’s exceptional leadership skills, extensive industry experience, and visionary approach, we are confident that she will steer our company towards growth and success. Colleen’s proven track record of innovation and commitment to excellence aligns perfectly with our strategic vision. We look forward to supporting her in this exciting new chapter for Selkirk.” — Jim Bell, Chairman of the Board at Selkirk Pharma
  • “I am honored to lead Selkirk Pharma into the next stage of its evolution. Our state-of-the-art facility, with its best-in-class labs and manufacturing technology, reflects the energy and dedication of our incredibly talented professionals. As we bring more capacity online to ensure a reliable supply of medications to patients, I am excited to drive our growth, foster innovation, and establish strong alliances that will benefit our stakeholders and customers in the aseptic fill/finish industry.” — Colleen Dixon, Chief Executive Officer at Selkirk Pharma

SoHC's Take

Colleen Dixon’s appointment as CEO of Selkirk Pharma signals a strategic shift towards leveraging extensive industry experience to enhance operational efficiency and drive growth. With her rich background in biopharma R&D and manufacturing, Dixon is well-positioned to lead Selkirk Pharma through its next growth phase. Her proven track record in strategic planning and organizational change management, coupled with her commitment to innovation, aligns perfectly with Selkirk’s vision of becoming the world’s most reliable manufacturer of injectable drug products. This leadership transition is poised to strengthen Selkirk Pharma’s market position and expand its capacity to meet increasing industry demands.

More To Explore

Total
0
Share